Mutations of BRAF and BIRC3 Identify a Subgroup of Chronic Lymphocytic Leukemia with Very Poor Prognosis upon FCR Treatment

被引：0

作者：

Moia, Riccardo ^{[1
]}

Diop, Fary ^{[1
]}

Favini, Chiara ^{[1
]}

Spaccarotella, Elisa ^{[1
]}

De Paoli, Lorenzo ^{[1
]}

Bruscaggin, Alessio ^{[2
]}

Spina, Valeria ^{[2
]}

Cerri, Michaela

Deambrogi, Clara ^{[1
]}

Kodipad, Ahad Ahmed ^{[1
]}

Favini, Simone ^{[1
]}

Sagiraju, Sruthi ^{[1
]}

Jabangwe, Clive ^{[1
]}

Mauro, Francesca Romana ^{[3
]}

Del Giudice, Ilaria ^{[3
]}

Forconi, Francesco ^{[4
,5
,6
]}

Cortelezzi, Agostino ^{[7
,8
]}

Zaja, Francesco ^{[9
]}

Visco, Carlo ^{[10
]}

Chiarenza, Annalisa ^{[11
]}

Rigolin, Gian Matteo ^{[12
]}

Marasca, Roberto ^{[13
]}

Coscia, Marta ^{[14
,15
]}

Perbellini, Omar ^{[16
]}

Tedeschi, Alessandra ^{[17
]}

Laurenti, Luca ^{[18
]}

Motta, Marina ^{[19
]}

Del Poeta, Giovanni ^{[20
]}

Cuneo, Antonio ^{[12
]}

Gattei, Valter ^{[21
]}

Foa, Robin ^{[3
]}

Gaidano, Gianluca ^{[1
]}

Rossi, Davide ^{[2
]}

机构：

[1] Amedeo Avogadro Univ Eastern Piedmont, Dept Translat Med, Div Hematol, Novara, Italy

[2] Inst Southern Switzerland, Inst Oncol Res & Oncol, Bellinzona, Switzerland

[3] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Hematol, Rome, Italy

[4] Univ Southampton, Southampton Canc Res UK, Canc Sci Unit, Southampton, Hants, England

[5] Univ Southampton, Natl Inst Hlth Res, Expt Canc Med Ctr, Southampton, Hants, England

[6] Univ Siena, Div Hematol, Siena, Italy

[7] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Hematol Oncol, Milan, Italy

[8] Univ Milan, Milan, Italy

[9] Univ Udine, DAME, Clin Ematol, Udine, Italy

[10] Osped San Bortolo, Dept Cell Therapy & Hematol, Vicenza, Italy

[11] Azienda Osped Univ Policlin OVE, Div Hematol, Catania, Italy

[12] Univ Ferrara, Azienda Osped Univ Arcispedale S Anna, Hematol Sect, Ferrara, Italy

[13] Univ Modena & Reggio Emilia, Dept Hematol & Oncol, Div Hematol, Modena, Italy

[14] Azienda Ospedaliero Univ Citta Salute & Sci, Div Hematol, Turin, Italy

[15] Univ Turin, Turin, Italy

[16] Univ Verona, Dept Med, Sect Hematol, Verona, Italy

[17] Osped Niguarda Ca Granda, Niguarda Canc Ctr, Dept Oncol Haematol, Milan, Italy

[18] Univ Cattolica Sacro Cuore, Inst Hematol, Rome, Italy

[19] Spedali Civil Brescia, Dept Hematol, Brescia, Italy

[20] Tor Vergata Univ, Dept Hematol, Rome, Italy

[21] IRCCS, Ctr Riferimento Oncol, Clin & Expt Oncohematol Unit, Aviano, Italy

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 10期

关键词：

chronic lymphocytic leukemia; FCR; immunochemotherapy; molecular predictors; precision medicine;

D O I：

10.1016/j.clml.2017.09.039

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CLL-009

引用

页码：S11 / S12

页数：2

共 50 条

[31] Single-agent rituximab in treatment-refractory or poor prognosis patients with chronic lymphocytic leukemia
Wiernik, Peter H.
Adiga, Giridhar U.
CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (10) : 1987 - 1993
[32] Single-Agent Rituximab in Treatment-Refractory or Poor Prognosis Patients with Chronic Lymphocytic Leukemia
Adiga, Giridhar U.
Wiernik, Peter H.
BLOOD, 2009, 114 (22) : 940 - 940
[33] NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment
Dal Bo, Michele
Del Principe, Maria Ilaria
Pozzo, Federico
Ragusa, Dario
Bulian, Pietro
Rossi, Davide
Capelli, Giovanni
Rossi, Francesca Maria
Niscola, Pasquale
Buccisano, Francesco
Bomben, Riccardo
Zucchetto, Antonella
Maurillo, Luca
de Fabritiis, Paolo
Amadori, Sergio
Gaidano, Gianluca
Gattei, Valter
Del Poeta, Giovanni
ANNALS OF HEMATOLOGY, 2014, 93 (10) : 1765 - 1774
[34] NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment
Michele Dal Bo
Maria Ilaria Del Principe
Federico Pozzo
Dario Ragusa
Pietro Bulian
Davide Rossi
Giovanni Capelli
Francesca Maria Rossi
Pasquale Niscola
Francesco Buccisano
Riccardo Bomben
Antonella Zucchetto
Luca Maurillo
Paolo de Fabritiis
Sergio Amadori
Gianluca Gaidano
Valter Gattei
Giovanni Del Poeta
Annals of Hematology, 2014, 93 : 1765 - 1774
[35] FAND/Alemtuzumab (Campath®, MabCampath®) therapy for the treatment of patients with poor-prognosis chronic lymphocytic leukemia.
Mauro, FR
Gentile, M
Giammartini, E
Gentile, G
Guarini, AR
De Propris, MS
Ghia, E
Borza, PA
Valle, V
Alimena, G
Foà, R
BLOOD, 2003, 102 (11) : 355B - 355B
[36] Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia
Sinclair, PB
Nacheva, EP
Leversha, M
Telford, N
Chang, J
Reid, A
Bench, A
Champion, K
Huntly, B
Green, AR
BLOOD, 2000, 95 (03) : 738 - 744
[37] TRAF3 Alterations Identify a Subgroup of Patients with Adverse Clinical Outcome and Induce Metabolic Reprogramming in Chronic Lymphocytic Leukemia
Perez Carretero, Claudia
Quijada Alamo, Miguel
Tannoury, Mariana
Dehgane, Lea
Sanz, David J.
Gonzalez, Teresa
Benito, Rocio
Chapiro, Elise
Hernandez-Sanchez, Maria
Rodriguez, Ana E.
Khac, Florence Nguyen
Susin, Santos A.
Maria Hernandez-Rivas, Jesus
BLOOD, 2022, 140 : 4105 - 4106
[38] High expression of PI3K core complex genes is associated with poor prognosis in chronic lymphocytic leukemia
Kristensen, Louise
Kristensen, Thomas
Abildgaard, Niels
Thomassen, Mads
Frederiksen, Mikael
Mourits-Andersen, Torben
Moller, Michael Boe
LEUKEMIA RESEARCH, 2015, 39 (06) : 555 - 560
[39] KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival
Elena Vendramini
Riccardo Bomben
Federico Pozzo
Dania Benedetti
Tamara Bittolo
Francesca Maria Rossi
Michele Dal Bo
Kari G. Rabe
Gabriele Pozzato
Francesco Zaja
Annalisa Chiarenza
Francesco Di Raimondo
Esteban Braggio
Sameer A. Parikh
Neil E. Kay
Tait D. Shanafelt
Giovanni Del Poeta
Valter Gattei
Antonella Zucchetto
Leukemia, 2019, 33 : 2111 - 2115
[40] KRAS, NRAS and BRAF Mutations Are Highly Enriched in TRI12 Chronic Lymphocytic Leukemia and Are Associated to Shorter Time to First Treatment
Vendramini, Elena
Bomben, Riccardo
Pozzo, Federico
Benedetti, Dania
Rossi, Maria Francesca
Dal Bo, Michele
Pozzato, Gabriele
Zaja, Francesco
Chiarenza, Annalisa
Di Raimondo, Francesco
Del Poeta, Giovanni
Gattei, Valter
Zucchetto, Antonella
BLOOD, 2018, 132

← 1 2 3 4 5 →